The Life Sciences team
Our Life Sciences team are experts in advising researchers on what steps they should take to protect their intellectual property and create robust innovations to attract industry investment.
Life Sciences Technologies
Ripestuff
A method for encapsulating ethylene gas to ripen fruit in transit.
Targeted therapy for Dravet syndrome and other forms of epilepsy
Novel peptide agonists as a potential targeted therapy for Dravet syndrome.
Rapid DNA readout system
A rapid method to visualise amplified DNA in just one-step.
Self-assembling, self-adjuvanting system for delivery of peptide-based vaccines
A novel peptide-based immunogenic agent that facilitates self-assembly with peptide epitopes into an immunogenic complex that has adjuvant…
Automated Topology Builder
The ATB provides users with accurate topologies and parameters for a wide range of organic molecules.
Nav1.7 Inhibitor
The UQ peptide termed Pn3a is a potent inhibitor of Nav1.7.
High loading core shell nanoparticles
UQ researchers have developed new approaches for the synthesis of polymer nanoparticles encapsulating insoluble small molecule drugs.
Therapeutic antibody for lymphoma, nasopharyngeal and gastric cancers
A therapeutic antibody for treatment of indications including advanced nasopharyngeal, gastric cancers and some lymphomas
Novel activator of locally resident immunity and immunotherapy
Novel activator of locally resident immunity and immunotherapy

Head of Life Sciences
Craig Belcher
Craig is a senior management professional with more than 20 years' experience in commercialising technology within the biotechnology and nanotechnology industries. He leads a team that identifies, patents and commercialises intellectual property from The University of Queensland related to human health, from therapeutics to diagnostics, genomics and the microbiome, to medical devices, as well as biological sciences, food and agriculture.
Innovation Pipelines
We have a suite of available technologies to give your business an innovative edge.